Social science: Include social equity in California Biohub
By Science FARE (Feminist Anti-Racist Equity) Collective: Jessica Cussins, Kate Weatherford Darling, Ugo Edu, Laura Mamo, Jenny Reardon & Charis Thompson,
Nature
| 10. 19. 2016
We have an idea for philanthropists Priscilla Chan and Mark Zuckerberg, who last month announced their first major investment in basic science: US$600 million for a Biohub in San Francisco, California.
They aspire to 'advance human potential and promote equality' (https://chanzuckerberg.com). As members of the Science FARE (Feminist Anti-Racist Equity) collective, we suggest that 5–7% of the Biohub's health-research budget should be used to design and monitor goals of justice and equality from the outset. Otherwise, social inequalities could limit the project's potential.
Innovative social scientists will need to work with bench scientists, engineers and clinical researchers. Health research should include trained people from all social backgrounds and a variety of disciplines.
The affordability of treatments and access to them is crucial, irrespective of class, gender, race or disabilities. Building equality into Biohub's founding architecture will allow it to be tackled simultaneously with disease eradication, mitigating the uneven social distribution of health care in San Francisco's Bay Area and beyond.
Image via C-Z BioHub
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
